IP Library › Assignment 070126/0361
Patent Assignment
Reel/Frame 070126/0361

Change of Name

Recorded: 2025-02-05 Pages: 4
Assignor
SANGAMO BIOSCIENCES, INC.
Executed: 2017-01-05
Assignee
SANGAMO THERAPEUTICS, INC.
7000 MARINA BLVD., BRISBANE, CALIFORNIA, 94005
Covered Property (1)
Methods and Compositions for Alteration of a Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) Gene
Patent: 9,161,995 →
Application: 13/558,101 →
Publication: US 2013/0145485
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License Nov 8, 2012
From: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029261/0726 →
Assignment of Assignor's Interest Feb 13, 2013
From: GUSCHIN, DMITRY; HOLMES, MICHAEL C.; PASCHON, DAVID; TAM, PHILLIP
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 029807/0627 →
Assignment of Assignor's Interest Feb 13, 2013
From: DAVIS, BRIAN R.
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 029807/0818 →
Confirmatory License Jan 31, 2023
From: THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 062568/0163 →